⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for ret gene mutation

Every month we try and update this database with for ret gene mutation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)NCT04222972
RET-fusion Non ...
Lung Neoplasm
Carcinoma, Non-...
Respiratory Tra...
Thoracic Neopla...
Neoplasms by Si...
Neoplasms
Lung Diseases
Respiratory Tra...
Carcinoma, Bron...
Bronchial Disea...
Head and Neck N...
Adenocarcinoma
Carcinoma
Neoplasms by Hi...
Neoplasms, Germ...
Neoplasms, Nerv...
Pralsetinib
Carboplatin
Cisplatin
Pemetrexed
Pembrolizumab
Gemcitabine
Paclitaxel
Nab-Paclitaxel
18 Years - Hoffmann-La Roche
The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLCNCT06109558
Non Small Cell ...
RET Gene Mutati...
MET Amplificati...
EGF-R Positive ...
LMV-12(HE003)
18 Years - Hunan Province Tumor Hospital
Continued Access to RXDX-105NCT03784378
Non Small Cell ...
Ovarian Cancer
RET Gene Mutati...
BRAF Gene Mutat...
RXDX-105
18 Years - Memorial Sloan Kettering Cancer Center
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsNCT03037385
RET-altered Non...
Medullary Thyro...
RET-altered Pap...
RET-altered Col...
RET-altered Sol...
Lung Neoplasm
Carcinoma, Non-...
Thyroid Disease...
Thyroid Neoplas...
Thyroid Cancer,...
Carcinoma, Neur...
Respiratory Tra...
Thoracic Neopla...
Neoplasms by Si...
Neoplasms
Lung Diseases
Respiratory Tra...
Carcinoma, Bron...
Bronchial Neopl...
Endocrine Syste...
Endocrine Gland...
Head and Neck N...
Adenocarcinoma,...
Adenocarcinoma
Carcinoma
Neoplasms, Glan...
Neoplasms by Hi...
Neuroendocrine ...
Neuroectodermal...
Neoplasms, Germ...
Neoplasms, Nerv...
Colonic Neoplas...
Colorectal Neop...
Intestinal Neop...
Gastrointestina...
Digestive Syste...
Digestive Syste...
Gastrointestina...
Colonic Disease...
Intestinal Dise...
pralsetinib (BL...
18 Years - Hoffmann-La Roche
Real-Time Monitoring of Symptoms in Lung Cancer Patients Receiving Oral Targeted TherapiesNCT05370469
Lung Cancer
EGFR Gene Mutat...
EGFR
ALK Gene Mutati...
RET Gene Mutati...
MET Gene Mutati...
KRAS Mutation-R...
BRAF
ROS1 Gene Mutat...
Sensus Smartwat...
RX Cap
Fitbit Sense
Surveys
18 Years - University of Virginia
Ponatinib in Advanced NSCLC w/ RET TranslocationsNCT01813734
Non Small Cell ...
Ponatinib
18 Years - Massachusetts General Hospital
The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLCNCT06109558
Non Small Cell ...
RET Gene Mutati...
MET Amplificati...
EGF-R Positive ...
LMV-12(HE003)
18 Years - Hunan Province Tumor Hospital
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: